The overall purpose of the study is to assess the efficacy of three different doses of BI 655064 against placebo as add-on therapy to standard of care (SOC) treatment for active lupus nephritis in order to characterize the dose-response relationship within the therapeutic range, and select the target dose for phase III development. Study sponsor: …
This multicenter trial is using a variety of kidney imaging tools, including magnetic resonance imaging to evaluate and monitor the kidneys of patients with lupus nephritis (LN) to determine if these non-invasive tools could replace surgical biopsy. To Learn More Contact Rebecca Bender at 434-477-2675 or rebeccabender@ampel.org ClinicalTrials.gov identifier: NCT03180021 …
This is a Phase 1b/2, multi-center study in which patients will receive KZR-616, administered as a subcutaneous injection weekly for 13 weeks. The study consists of 2 parts. Part 1, the Phase 1b, is an open-label multiple dose escalation study to evaluate the safety and tolerability of KZR-616 in patients with systemic lupus erythematosus (SLE) with …
The purpose of thisPhase 3 study is assess the long-term safety and tolerability of voclosporin compared with placebo for up to an additional 24 months following completion of treatment in the AURORA 1 study in subjects with lupus nephritis (LN). To Learn More Contact GS-US-437-4093@gilead.com ClinicalTrials.gov identifier: NCT03285711 …
The purpose of thisPhase 3 study is assess the long-term safety and tolerability of voclosporin compared with placebo for up to an additional 24 months following completion of treatment in the AURORA 1 study in subjects with lupus nephritis (LN). To Learn More Contact Antonia Coeshall at 441962715493 or acoeshall@auriniapharma.com Laura Lisk at (0)7790555604 or llisk@auriniapharma.com …
Use this tool to search all lupus trials and create a personalized list of studies by the type of lupus you have and where you live.
LupusTrials.org